The electrocardiogram (ECG) remains a cornerstone in cardiovascular diagnostics, yet its clinical utility is often compromised by signal distortions introduced during acquisition. Contemporary ...
MaxYield targets signal distortions commonly seen in mobile, wearable, and dynamic clinical environments-such as motion artifacts, low-amplitude waveforms, baseline wander, and non-physiological noise ...
TORONTO, ON / ACCESS Newswire / November 11, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leader in AI-powered physiological signal interpretation, is ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, the AccurECG™ Analysis System ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Automated ECG interpretation system gains FDA clearance ...
Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...
Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML ...